ALEXANDRIA, Va., June 16 -- United States Patent no. 12,305,195, issued on May 20, was assigned to University of Rochester (Rochester, N.Y.).

"Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders" was invented by Steven A. Goldman (Webster, N.Y.) and Su Wang (Rochester, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a preparation of CD140a/PDGFRAlpha positive cells that comprises oligodendrocyte progenitor cells co-expressing OLIG2 and CD140a/PDGFRAlpha. The preparation of cells is derived from pluripotent cells that were derived from skin cells, fibroblasts, umbilical cord blood, peripheral blood, bone marrow, or other...